Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia

Anti-Cancer Drugs

Volumn 24, Issue 10, 2013, Pages 1098-1103

  Pérez, Mayrim L ^a   Culver, Sarah ^b   Owen, Jennifer L ^a   Dunbar, Mark ^a   Kow, Kelvin ^a   Breen, Matthew ^b,c   Milner, Rowan J ^a  

^a University of Florida   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cytogenetic analysis; fluorescence in situ hybridization; monocytosis; toceranib; tyrosine kinase inhibitor

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BCR ABL PROTEIN; CD34 ANTIGEN; ENROFLOXACIN; IMATINIB; PREDNISONE; TOCERANIB;

ANIMAL TISSUE; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CYTOGENETICS; DOG; DRUG USE; EOSINOPHIL; FEMALE; GRANULOPOIESIS; LEUKEMIA REMISSION; LEUKOCYTOSIS; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTOSIS; MEGAKARYOPOIESIS; MONOCYTIC LEUKEMIA; MONOCYTOSIS; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL PROLIFERATION; DOG DISEASES; DOGS; FEMALE; FUSION PROTEINS, BCR-ABL; IN SITU HYBRIDIZATION, FLUORESCENCE; INDOLES; LEUKEMIA, MYELOID; PREDNISONE; PYRROLES; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 84885370605     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000018     Document Type: Article

References (25)

1. Cruz Cardona JA, Milner R, Alleman AR, Williams C, Vernau W, Breen M, et al. BCR-ABL translocation in a dog with chronic monocytic leukemia. Vet Clin Pathol 2011; 40:40-47.
2. Helfand SC, Kisseberth WC. General features of leukemia and lymphoma. In: Weiss DJ,Wardrop KJ, editors. Schalm's veterinary hematology. 6th ed. Ames: Blackwell Publishing Ltd.; 2010. pp. 455-465.
3. Leifer C, Matus R, Patnaik A, MacEwen E. Chronic myelogenous leukemia in the dog. J Am Vet Med Assoc 1983; 193:686-689.
4. ValliV. Chronic myeloproliferative diseases. Veterinary comparative hematopathology. 1st ed. Oxford: Blackwell Publishing; 2008. pp. 425-434.
5. Rossi G, Gelain ME, Foroni S, Comazzi S. Extreme monocytosis in a dog with chronic monocytic leukaemia. Vet Rec 2009; 165:54-56.
6. Gorman NT, Evans RJ. Myeloproliferative disease in the dog and cat: Clinical presentations, diagnosis and treatment. Vet Rec 1987; 121:490-496.
7. Grindem CB, Stevens JB, Brost DR, Johnson DD. Chronic myelogenous leukaemia with meningeal infiltration in a dog. Comp Haematol Int 1992; 2:170-174.
8. Tarrant JM, Stokol T, Blue JT, McDonough SP, Farrell P. Diagnosis of chronic myelogenous leukemia in a dog using morphologic, cytochemical, and flow cytometric techniques. Vet Clin Pathol 2001; 30:19-24.
9. Dunn JK, Jefferies AR, Evans RJ, Herrtage ME. Chronic granulocytic leukaemia in a dog with associated bacterial endocarditis, thrombocytopenia and preretinal and retinal hemorrhages. J Small Anim Pract 1987; 28:1079-1086.
10. Ndikuwera J, Smith DA, Obwolo MJ, Masvingwe C. Chronic granulocytic leukaemia/eosinophilic leukaemia in a dog. J Small Anim Pract 1992; 33:553-557.
11. McManus PM. Classification of myeloid neoplasms: A comparative review. Vet Clin Pathol 2005; 34:189-212.
12. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosomepositive leukemias: From basic mechanisms to molecular therapeutics. Ann Intern Med 2003; 138:819-830.
13. Modiano JF, Breen M. Shared pathogenesis of human and canine tumors-an inextricable link between cancer and evolution. Cancer Ther 2008; 6:239-246.
14. Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 2007; 7:345-356.
15. Breen M, Modiano JF. Evolutionary conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 2008; 16:145-154.
16. Breen M, Jouquand S, Renier C, Mellersh CS, Hitte C, Holmes NG, et al. Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage Map of the domestic dog genome to all chromosomes. Genome Res 2001; 11:1784-1795.
17. Culver S, Ito D, Borst L, Bell JS, Modiano JF, Breen M. Molecular characterization of canine BCR-ABL positive chronic myelomonocytic leukemia before and after chemotherapy. Vet Clin Pathol 2013; doi:10.1111/vcp.12055.
18. Figueiredo JF, Culver S, Behling-Kelly E, Breen M, Friedrichs KR. Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog. Vet Clin Pathol 2012; 41:362-368.
19. Yancey MF, Merritt DA, Lesman SP, Boucher JF, Michels GM. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors. J Vet Pharmacol Ther 2010; 33:162-171.
20. London C, Mathie T, Clifford C, Haney S, Klein MK, Beaver L, et al. Preliminary evidence for biologic activity of toceranib phosphate (Palladia) in solid tumours. Vet Comp Oncol 2011; 10:194-205.
21. Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999; 69:145-164.
22. Lee SJ, Jung CW, Kim D, Lee K, Sohn SK, Kwak J, et al. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia. Am J Hematol 2011; 86:346-350.
23. Joiner GN, Fraser CJ, Jardine JH, Trujillo JM. A case of chronic granulocytic leukemia in a dog. Can J Comp Med 1976; 40:153-160.
24. Mackey LJ. Monocytic leukaemia in the dog. Vet Rec 1975; 96:27-30.
25. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, et al. Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol 2000; 18:1533-1538.